We are live on ! Find out more
KIDS icon

OrthoPediatrics

118 hedge funds and large institutions have $620M invested in OrthoPediatrics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

194% more call options, than puts

Call options by funds: $362K | Put options by funds: $123K

20% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 35

5.77% less ownership

Funds ownership: 75.51%69.74% (-5.8%)

6% less funds holding

Funds holding: 126118 (-8)

12% less capital invested

Capital invested by funds: $706M → $620M (-$85.6M)

29% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 24

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
118
Holders Change
-8
Holders Change %
-6.35%
% of All Funds
1.9%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
17
Increased
42
Reduced
35
Closed
24
Calls
$362K
Puts
$123K
Net Calls
+$239K
Net Calls Change
+$668K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
76
UBS Group
Switzerland
$278K +$198K +4,763 +213%
GTCM
77
Gyon Technologies Capital Management
New Jersey
$274K +$287K +6,886 New
Deutsche Bank
78
Deutsche Bank
Germany
$270K +$4.21K +101 +2%
Stifel Financial
79
Stifel Financial
Missouri
$265K +$51.2K +1,230 +23%
US Bancorp
80
US Bancorp
Minnesota
$253K -$22.2K -533 -8%
State Board of Administration of Florida Retirement System
81
State Board of Administration of Florida Retirement System
Florida
$243K
Citigroup
82
Citigroup
New York
$241K -$73K -1,752 -22%
Manulife (Manufacturers Life Insurance)
83
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$237K +$8K +192 +3%
VOYA Investment Management
84
VOYA Investment Management
Georgia
$231K
Legal & General Group
85
Legal & General Group
United Kingdom
$218K +$3.29K +79 +1%
UBS AM
86
UBS AM
Illinois
$211K
Russell Investments Group
87
Russell Investments Group
United Kingdom
$180K
Barclays
88
Barclays
United Kingdom
$162K +$143K +3,441 +544%
AB
89
Amalgamated Bank
New York
$96K
AIM
90
Arcadia Investment Management
Michigan
$85.7K +$89.9K +2,158 New
Lazard Asset Management
91
Lazard Asset Management
New York
$84K
PFBT
92
Parkside Financial Bank & Trust
Missouri
$70.7K +$42 +1 +0.1%
BNP Paribas Financial Markets
93
BNP Paribas Financial Markets
France
$68.6K -$212K -5,077 -75%
Wells Fargo
94
Wells Fargo
California
$63.6K -$7.5K -180 -10%
Zurich Cantonal Bank
95
Zurich Cantonal Bank
Switzerland
$56.2K
SOW
96
State of Wyoming
Wyoming
$54.8K +$10.8K +259 +23%
AIP
97
Ameritas Investment Partners
Nebraska
$50.3K
Osaic Holdings
98
Osaic Holdings
Arizona
$46K -$5.54K -133 -10%
HIA
99
Harbor Investment Advisory
Maryland
$36.8K -$14.4K -345 -27%
MLICM
100
Metropolitan Life Insurance Company (MetLife)
New York
$36.4K

KIDS Hedge Fund Activity: Q4 2022 in Review

118 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q4 2022, worth a combined $620M — down 12% from $706M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of KIDS and 17 opened new positions — a net loss of 7 holders — while 35 trimmed existing stakes and 42 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $10.4M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $11.7M sold.

  • 118 institutional investors held OrthoPediatrics (KIDS) as of Q4 2022, down from 126 in Q3 2022.
  • Funds reported $620M of OrthoPediatrics stock for Q4 2022, down 12% quarter-over-quarter.
  • 17 funds opened new OrthoPediatrics positions in Q4 2022 and 24 closed out, a net change of -7 holders.
  • The largest OrthoPediatrics buyer in Q4 2022 was Millennium Management, an estimated $10.4M added.
  • The largest OrthoPediatrics seller in Q4 2022 was Lord, Abbett & Co, an estimated $11.7M sold.

Based on aggregated 13F filings for Q4 2022.